全部文献期刊学位论文会议报纸专利标准年鉴图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Kyoichi Kaira , Reiko Sakurai ...
来源:[J].International Journal of Clinical Oncology(IF 1.727), 2017, Vol.22 (5), pp.872-879Springer
摘要:Glucose-regulated protein (GRP) 78/immunoglobulin heavy chain binding protein (BiP) is a member of the endoplasmic reticulum chaperone family, and its role in various types of human malignancies has recently been investigated. However, the clinicopathological characteristics of G...
作者:Kyoichi Kaira , Kenya Kanazawa ...
来源:[J].Cancer Chemotherapy and Pharmacology(IF 2.795), 2017, Vol.80 (3), pp.615-622Springer
摘要:Amrubicin is one of the most active chemotherapeutic drugs for small cell lung cancer (SCLC). Previous studies reported its effectiveness and severe hematological toxicity. However, the efficacy of amrubicin monotherapy in elderly patients with SCLC has not been described. The ob...
作者:Kyoichi Kaira , Keita Mori ...
来源:[J].BMC Cancer(IF 3.333), 2015, Vol.15 (1)Springer
摘要:Abstract(#br) Background(#br)To investigate the prognostic significance of patient characteristics and clinical laboratory test results in locally advanced non-small cell lung cancer (NSCLC), and in particular the impact of diabetes mellitus (DM) on the survival of patients who u...
作者:Kyoichi Kaira , Akihiro Yoshii ...
来源:[J].Journal of Cancer Research and Therapeutics(IF 0.761), 2015, Vol.11 (3), pp.606-611DOAJ
摘要:Introduction: The effects of first-line single-agent chemotherapy on overall survival (OS) might be confounded by subsequent treatments in elderly patients with nonsmall cell lung cancer (NSCLC). We, therefore, aimed to evaluate whether progression-free survival (PFS), postprogre...
作者:Kyoichi Kaira , Haruyasu Murakami ...
来源:[J].Annals of Thoracic Medicine(IF 1.123), 2015, Vol.10 (1), pp.61-66DOAJ
摘要:Objectives: The effects of first-line chemotherapy on overall survival (OS) might be confounded by subsequent therapies in patients with small cell lung cancer (SCLC). We examined whether progression-free survival (PFS), post-progression survival (PPS), and tumor response co...
作者:... Akito Maeshima , Kyoichi Kaira , Masanobu Yamada
来源:[J].Scientific Reports(IF 2.927), 2019, Vol.9 (1), pp.1-11DOAJ
摘要:Abstract The new type 2 diabetes drug, dapagliflozin, reduces blood glucose levels and body weight by inhibiting sodium glucose transporter 2 (SGLT2) in proximal tubular cells. SGLT2 inhibitors might modulate glucose influx into renal tubular cells, thereby regulating the me...
作者:Kyoichi Kaira , Yukio Kato ...
来源:[J].Journal of Pharmacological Sciences(IF 2.15), 2016, Vol.130 (2), pp.101-109Elsevier
摘要:Abstract(#br)A PET tracer for tumor imaging, 3- 18 F- l - α -methyl-tyrosine ([ 18 F]FAMT), has advantages of high cancer-specificity and low physiological background. In clinical studies, FAMT-PET has been proved useful for the detection of malignant tumors and their differ...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×